Table 4 Logistic regression in eyes with visual improvement.
Location | Variable | B | S.E. | p | Exp (B) |
|---|---|---|---|---|---|
Central edema | Baseline visual impairment | −2.442 | 0.447 | 0.000* | 0.087 |
Male gender | 0.830 | 0.408 | 0.042* | 2.293 | |
Center field thickening | 2.064 | 1.391 | 0.138 | 7.878 | |
Center point thickening | 0.869 | 0.732 | 0.235 | 2.384 | |
Arterial hypertension | 0.481 | 0.414 | 0.245 | 1.618 | |
Central edema | −1.578 | 1.536 | 0.304 | 0.206 | |
Proliferative retinopathy | −0.185 | 0.444 | 0.677 | 0.831 | |
Macular volume enlargement | −0.140 | 0.446 | 0.754 | 0.869 | |
Constant | 0.591 | 0.391 | 0.131 | 1.806 | |
Central and paracentral edema | Baseline visual impairment | −2.475 | 0.455 | 0.000* | 0.084 |
Male gender | 0.863 | 0.406 | 0.034* | 2.369 | |
Arterial hypertension | 0.532 | 0.413 | 0.198 | 1.702 | |
Center field thickness | 0.693 | 0.722 | 0.337 | 2.000 | |
Center point thickness | 0.447 | 0.647 | 0.489 | 1.564 | |
Proliferative retinopathy | −0.259 | 0.441 | 0.556 | 0.772 | |
Central and paracentral edema | −0.261 | 0.590 | 0.658 | 0.770 | |
Macular volume enlargement | −0.104 | 0.449 | 0.817 | 0.902 | |
Constant | 0.707 | 0.613 | 0.249 | 2.029 |